The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran
H Ichiki, N Oketani, S Ishida, Y Iriki… - Pacing and Clinical …, 2013 - Wiley Online Library
H Ichiki, N Oketani, S Ishida, Y Iriki, H Okui, R Maenosono, F Namino, Y Ninomiya, M Miyata…
Pacing and Clinical Electrophysiology, 2013•Wiley Online LibraryBackground Cerebral microthromboembolism after atrial fibrillation (AF) ablation has been
reported in 4–20% with perioperative warfarin. Dabigatran is a new anticoagulant in patients
with nonvalvular AF. We investigated the incidence of asymptomatic cerebral
microthromboembolism after AF ablation with perioperative warfarin or dabigatran using
diffusion‐weighted and T2‐weighted magnetic resonance imaging (MRI). Methods and
Results Our study included 210 consecutive patients with AF (111 paroxysmal and 99 …
reported in 4–20% with perioperative warfarin. Dabigatran is a new anticoagulant in patients
with nonvalvular AF. We investigated the incidence of asymptomatic cerebral
microthromboembolism after AF ablation with perioperative warfarin or dabigatran using
diffusion‐weighted and T2‐weighted magnetic resonance imaging (MRI). Methods and
Results Our study included 210 consecutive patients with AF (111 paroxysmal and 99 …
Background
Cerebral microthromboembolism after atrial fibrillation (AF) ablation has been reported in 4–20% with perioperative warfarin. Dabigatran is a new anticoagulant in patients with nonvalvular AF. We investigated the incidence of asymptomatic cerebral microthromboembolism after AF ablation with perioperative warfarin or dabigatran using diffusion‐weighted and T2‐weighted magnetic resonance imaging (MRI).
Methods and Results
Our study included 210 consecutive patients with AF (111 paroxysmal and 99 persistent) who underwent complex fractionated atrial electrogram‐guided ablation (combined with pulmonary vein isolation, n = 110). Catheter irrigation was performed in all cases. Uninterrupted warfarin therapy was used in 180 patients (warfarin group) and interrupted only on the morning of the procedure with dabigatran in 30 (dabigatran group). All patients underwent cerebral MRI the day after ablation. New microthromboemboli were detected in 10.0% of the warfarin group and 26.7% of the dabigatran group (P < 0.05). The incidence of hemopericardium treated with pericardiocentesis was lower in the warfarin group than in the dabigatran group (2.5% vs 11.1%, P < 0.05). In multivariate analysis, the use of cardioversion was a predictor of new microthromboembolism development after AF ablation.
Conclusions
The incidence of asymptomatic cerebral microthromboembolism and hemopericardium after AF ablation was significantly lower with perioperative warfarin therapy than with dabigatran therapy. Dabigatran may not be an effective alternative to warfarin for AF ablation, especially in patients who undergo cardioversion.
Wiley Online Library以上显示的是最相近的搜索结果。 查看全部搜索结果